People: Concert Pharmaceuticals Inc (CNCE.OQ)
18 Apr 2019
Dr. James V. Cassella, Ph.D., is the Chief Development Officer of Concert Pharmaceuticals Inc, since February 2015. Prior to joining Concert, Dr. Cassella served as Executive Vice President, Research and Development and Chief Scientific Officer of Alexza Pharmaceuticals from July 2012 to January 2015 and served as its Senior Vice President, Research and Development from June 2004 to July 2012. From April 1989 to April 2004, Dr. Cassella held various management positions at Neurogen Corporation, a publicly traded biotechnology company. Prior to Neurogen, Dr. Cassella was Assistant Professor of Neuroscience at Oberlin College. Dr. Cassella received a Ph.D. in physiological psychology from Dartmouth College, completed a postdoctoral fellowship in the Department of Psychiatry at the Yale University School of Medicine and received a B.A. in psychology from the University of New Haven.
|Total Annual Compensation, USD||406,445|
|Restricted Stock Award, USD||832,200|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||721,591|
|Fiscal Year Total, USD||1,960,240|